Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 762544

Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers


Bezić, Joško; Šamija Projić, Ivana; Projić, Petar; Ljubković, Jelena; Zekić Tomaš, Sandra; Meljanac Salopek, Kristina; Piljić Burazer, Marina; Tomić, Snježana
Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers // Virchows Archiv, 466 (2015), 2; 185-189 doi:10.1007/s00428-014-1694-3 (međunarodna recenzija, članak, znanstveni)


Naslov
Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers

Autori
Bezić, Joško ; Šamija Projić, Ivana ; Projić, Petar ; Ljubković, Jelena ; Zekić Tomaš, Sandra ; Meljanac Salopek, Kristina ; Piljić Burazer, Marina ; Tomić, Snježana

Izvornik
Virchows Archiv (0945-6317) 466 (2015), 2; 185-189

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
male breast cancer; female breast cancer; DNA flow cytometry; ploidy; hypertetraploidy

Sažetak
The aim of the study was to explore possible differences in DNA flow cytometric characteristics, particularly differences in distribution of DNA indices of aneuploid clones, between male and female breast cancers. We retrospectively analyzed 31 male breast cancers. Clinicopathological and DNA flow cytometric characteristics of male breast cancers (patient age, tumor size, histological type, histological grade, axillary lymph node status, hormone receptor expression, ploidy, and Sphase fraction) were compared with that of the control group of matched female breast cancers. Hormone receptors and HER-2/ neu were investigated immunohistochemically with additional chromogenic in situ hybridization (CISH) analysis of HER-2/ neu 2+ cases. Ploidy and S-phase fraction were determined by DNA flow cytometry. Comparison with clinicopathological features was made using χ2 and t test. Aneuploidy was found in 78 % of the cases, with the predomination of hypotetraploid clones (39 %), followed by tetraploid (23 %) and hypertetraploid clones (16 %). We found higher frequency of hypertetraploidy in male breast cancers (16 and 6 %, respectively) than in the control group of matched female breast cancers. Clinicopathological features of hypertetraploid male breast cancers did not differ from that of non-hypertetraploid cancers. Higher frequency of hypertetraploidy among male breast cancers might indicate different cytogenetical evolutionary pathway between male and female breast cancer.

Izvorni jezik
Engleski



POVEZANOST RADA


Ustanove
Medicinski fakultet, Zagreb,
KBC Split

Citiraj ovu publikaciju

Bezić, Joško; Šamija Projić, Ivana; Projić, Petar; Ljubković, Jelena; Zekić Tomaš, Sandra; Meljanac Salopek, Kristina; Piljić Burazer, Marina; Tomić, Snježana
Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers // Virchows Archiv, 466 (2015), 2; 185-189 doi:10.1007/s00428-014-1694-3 (međunarodna recenzija, članak, znanstveni)
Bezić, J., Šamija Projić, I., Projić, P., Ljubković, J., Zekić Tomaš, S., Meljanac Salopek, K., Piljić Burazer, M. & Tomić, S. (2015) Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers. Virchows Archiv, 466 (2), 185-189 doi:10.1007/s00428-014-1694-3.
@article{article, year = {2015}, pages = {185-189}, DOI = {10.1007/s00428-014-1694-3}, keywords = {male breast cancer, female breast cancer, DNA flow cytometry, ploidy, hypertetraploidy}, journal = {Virchows Archiv}, doi = {10.1007/s00428-014-1694-3}, volume = {466}, number = {2}, issn = {0945-6317}, title = {Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers}, keyword = {male breast cancer, female breast cancer, DNA flow cytometry, ploidy, hypertetraploidy} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati